Elasto-Gel Hypothermia Cranial Helmet

When using the cap in combination with other treatments such as Chemotherapy: Docetaxel, Taxotere Epirubicin-Based, Mitozantrone, Vinorelbine, etc….(Various Chemotherapy Drugs). Studies have proven that hair loss may be reduced by using the cap 15 minutes before the chemotherapy treatment is initiated and continued use up to 30-40 minutes after therapy is completed. The cap should be replaced with another cold cap every 30 minutes throughout the chemo therapy application for best results. The cap should be held firmly against the head. Gauze or elastic wrap may be advantageous. Protect the ears and forehead with gauze or cotton to prevent frostbite. This procedure will provide continuous vasoconstriction with a reduced blood flow to the scalp, leading to a reduction in the quantity of drugs reaching the hair follicles and reduces the loss of hair. This means that the drug is present at high concentrations in the capillary circulation for a duration which is shorter than that of hypothermia. The reduction of the cellular uptake of the treatment drugs by the hair follicles may also be attributed to the lower temperature. Some research scientists have concluded that, a reduction in the metabolism of local tissue, in response to low temperature rather than reduced blood flow, is the most significant factor in preventing alopecia.